U.S. Markets open in 7 hrs 35 mins

AstraZeneca CEO: Brilinta can do "far better," Reuters reports

AstraZeneca's (AZN) new CEO Pascal Soriot believes Brilinta is the company's best product and can do "far better" than it has, Reuters reports. The executive says the company will look at acquisition opportunities to bolster its pipeline.